Biosimilar Market Trends, 2019

Description:

Biosimilar Market Trends, 2019 offers insights into the dynamic landscape of biosimilar markets worldwide. This comprehensive report delves into the strategies employed by both innovator and generic companies, providing a snapshot of key trends and issues influencing the biosimilar industry. With coverage spanning biopharmaceuticals, the report examines regulatory environments, market opportunities, and challenges, offering invaluable market data and analysis.

Key components include:

• Overview of Biosimilar Market Landscape
• Global Market Opportunities and Growth Trends
• Legislative and Regulatory Challenges
• Competitive Analysis and Strategies
• Market Expansion and Future Outlook

The report serves as a vital resource for industry professionals seeking to navigate the complexities of the biosimilar market, offering actionable insights and strategic recommendations. For those interested in understanding the evolving landscape of biopharmaceuticals, Biosimilar Market Trends, 2019 is an indispensable guide.

For further details and to purchase directly, please contact us.

Sample Report: A sample is available as a PDF upon request.

 

 

 

 

 

 

 

 

 

 

 

 

 

Table: Select Marketed Biologics with Active Patents

Product	Brand Manufacturer(s)	2018 $ Sales (billions USD)	Patent Approval	Earliest Patent Expiration	Generic Company Development
Advate	Shire	$XX Billion	2003	2024
Enbrel	Pfizer/Amgen/Takeda	$XX Billion	1998	2028	X
Herceptin	Roche	$XX Billion	1998	2019	X
Ilaris	Novartis	$XX Billion	2009	2021
Intron A	Merck	$XX Billion	1997	2020
Levemir	Novo Nordisk	$XX Billion	2005	2019	X
Lucentis	Genentech	$XX Billion	2006	2019
Orencia	BMS	$XX Billion	2005	2019	X
Pegasys/Copegus	Roche	$XX Billion	2002	2019	X
Pulmozyme	Genentech	$XX Billion	1993	2019
Simponi	J&J	$XX Billion	2009	2024
Soliris	Alexion	$XX Billion	2007	2019	X
Sprycel	BMS	$XX Billion	2006	2020
Stelara	J&J	$XX Billion	2009	2021	X
Yervoy	BMS	$XX Billion	2009	2020, 2022

Source: Kalorama Information